Aveanna Healthcare (NASDAQ:AVAH) Price Target Raised to $1.40 at Truist Financial

Aveanna Healthcare (NASDAQ:AVAH – Get Rating) had its price objective upped by Truist Financial from $1.00 to $1.40 in a research note issued on Friday, Benzinga reports. The firm currently has a “hold” rating on the stock. Truist Financial’s price target would indicate a potential upside of 7.69% from the company’s current price.

A number of other analysts also recently commented on AVAH. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of Aveanna Healthcare from $3.00 to $1.70 in a report on Friday. Royal Bank of Canada downgraded shares of Aveanna Healthcare from an “outperform” rating to a “sector perform” rating and decreased their price objective for the stock from $7.00 to $3.00 in a report on Monday, November 21st. Finally, Credit Suisse Group downgraded shares of Aveanna Healthcare from a “neutral” rating to an “underperform” rating and decreased their price objective for the stock from $2.00 to $1.00 in a report on Friday, January 27th. Two research analysts have rated the stock with a sell rating, four have issued a hold rating, two have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $2.34.

Aveanna Healthcare Stock Down 6.5 %

Shares of Aveanna Healthcare stock opened at $1.30 on Friday. Aveanna Healthcare has a 52-week low of $0.67 and a 52-week high of $6.00. The company’s 50-day simple moving average is $1.25 and its 200-day simple moving average is $1.22. The company has a current ratio of 0.89, a quick ratio of 0.89 and a debt-to-equity ratio of 5.63.

Institutional Trading of Aveanna Healthcare

Institutional investors and hedge funds have recently modified their holdings of the business. Zurcher Kantonalbank Zurich Cantonalbank purchased a new stake in shares of Aveanna Healthcare in the second quarter valued at about $25,000. SG Americas Securities LLC purchased a new stake in shares of Aveanna Healthcare in the second quarter valued at about $38,000. Delphia USA Inc. purchased a new stake in shares of Aveanna Healthcare in the first quarter valued at about $60,000. BNP Paribas Arbitrage SNC acquired a new position in shares of Aveanna Healthcare in the third quarter valued at approximately $33,000. Finally, Envestnet Asset Management Inc. raised its position in shares of Aveanna Healthcare by 15.7% in the first quarter. Envestnet Asset Management Inc. now owns 26,363 shares of the company’s stock valued at $90,000 after buying an additional 3,569 shares during the last quarter. Hedge funds and other institutional investors own 91.65% of the company’s stock.

Aveanna Healthcare Company Profile

(Get Rating)

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals.